Related Experiment Videos
Genetics and global health care
1Genetic Unit, College of Medicine and Health Sciences, Sultan Qaboos University, POB 35, Muscat 123, Sultanate of Oman. raeburn@squ.edu.om
Community Genetics
|March 16, 2005
Summary
Global genetic healthcare funding is insufficient, especially in developing nations. An insurance model could equitably fund rare genetic disorders worldwide.
Area of Science:
- Genetics
- Healthcare Economics
- Global Health
Background:
- Genetic health care faces significant funding challenges globally.
- Existing healthcare funding models are insufficient to cover the costs associated with genetic disorders.
Purpose of the Study:
- To explore alternative funding models for global genetic healthcare.
- To assess the feasibility of an insurance-based approach for rare genetic disorders.
Main Methods:
- Analysis of internet-based national data.
- Examination of gross domestic product (GDP) per capita.
- Evaluation of healthcare funding and cost structures (public and private).
Main Results:
- Significant disparities exist in GDP per capita and healthcare funding proportions worldwide.
- Developing countries face substantial deficits in available funds for healthcare.
- Current funding is inadequate for comprehensive genetic disorder care.
Conclusions:
- Full funding for genetic health care is improbable without alternative cost management strategies.
- An insurance model offers a potentially more equitable solution for funding rare genetic disorders.
- This model could be developed to address total global healthcare costs for genetic conditions.